| 0 |
BREAST NECROSIS |
1 |
0.0048 |
| 1 |
CEREBRAL TOXOPLASMOSIS |
2 |
0.0021 |
| 2 |
MENTAL DISABILITY |
1 |
0.0017 |
| 3 |
CUTANEOUS SYMPTOM |
1 |
0.0015 |
| 4 |
FUNGAL OESOPHAGITIS |
1 |
0.0014 |
| 5 |
ESCHAR |
1 |
0.0014 |
| 6 |
EYELID EXFOLIATION |
1 |
0.0013 |
| 7 |
CHEMICAL BURN OF SKIN |
3 |
0.0012 |
| 8 |
FOOD REFUSAL |
1 |
0.0011 |
| 9 |
ABDOMINAL NEOPLASM |
1 |
0.0011 |
| 10 |
SKIN SENSITISATION |
1 |
0.0010 |
| 11 |
SENSITIVE SKIN |
7 |
0.0009 |
| 12 |
EYELID SKIN DRYNESS |
1 |
0.0008 |
| 13 |
SUBCUTANEOUS HAEMATOMA |
1 |
0.0008 |
| 14 |
DISCHARGE |
1 |
0.0007 |
| 15 |
ACNE CYSTIC |
2 |
0.0007 |
| 16 |
INTENTIONAL UNDERDOSE |
4 |
0.0005 |
| 17 |
SEBORRHOEA |
2 |
0.0005 |
| 18 |
PAIN OF SKIN |
13 |
0.0005 |
| 19 |
APPLICATION SITE SCAB |
1 |
0.0005 |
| 20 |
ESCHERICHIA BACTERAEMIA |
1 |
0.0004 |
| 21 |
SKIN FRAGILITY |
1 |
0.0004 |
| 22 |
APPENDICITIS PERFORATED |
1 |
0.0004 |
| 23 |
SKIN IRRITATION |
18 |
0.0004 |
| 24 |
SKIN DISCOMFORT |
1 |
0.0004 |
| 25 |
SKIN BURNING SENSATION |
24 |
0.0003 |
| 26 |
DRY SKIN |
42 |
0.0003 |
| 27 |
SKIN EXFOLIATION |
26 |
0.0003 |
| 28 |
LYMPHOCYTE COUNT INCREASED |
1 |
0.0003 |
| 29 |
SKIN INJURY |
1 |
0.0003 |
| 30 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 31 |
SCAB |
3 |
0.0003 |
| 32 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 33 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 34 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 35 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 36 |
HYPERKERATOSIS |
1 |
0.0002 |
| 37 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 38 |
ENTEROCOLITIS |
1 |
0.0002 |
| 39 |
ACNE |
13 |
0.0002 |
| 40 |
UNDERDOSE |
10 |
0.0001 |
| 41 |
PEMPHIGOID |
1 |
0.0001 |
| 42 |
HYPERAESTHESIA |
1 |
0.0001 |
| 43 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 44 |
ANURIA |
1 |
0.0001 |
| 45 |
MUSCLE STRAIN |
1 |
0.0001 |
| 46 |
SKIN SWELLING |
1 |
0.0001 |
| 47 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 48 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 49 |
INTENTIONAL PRODUCT MISUSE |
9 |
0.0001 |
| 50 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 51 |
ERYTHEMA |
21 |
0.0001 |
| 52 |
APPLICATION SITE PAIN |
2 |
0.0001 |
| 53 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 54 |
BLISTER |
5 |
0.0001 |
| 55 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 56 |
RASH MACULAR |
3 |
0.0001 |
| 57 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 58 |
LIMB INJURY |
2 |
0.0001 |
| 59 |
TACHYPNOEA |
1 |
0.0001 |
| 60 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 61 |
TENDONITIS |
1 |
0.0001 |
| 62 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
11 |
0.0001 |
| 63 |
SCAR |
1 |
0.0001 |
| 64 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 65 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 66 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 67 |
RASH PAPULAR |
1 |
0.0000 |
| 68 |
APPLICATION SITE PRURITUS |
1 |
0.0000 |
| 69 |
HYPOPHAGIA |
1 |
0.0000 |
| 70 |
SKIN ULCER |
1 |
0.0000 |
| 71 |
APPLICATION SITE ERYTHEMA |
1 |
0.0000 |
| 72 |
PNEUMONITIS |
1 |
0.0000 |
| 73 |
MOOD ALTERED |
1 |
0.0000 |
| 74 |
PRODUCT USE IN UNAPPROVED INDICATION |
9 |
0.0000 |
| 75 |
HYPERSOMNIA |
1 |
0.0000 |
| 76 |
DYSSTASIA |
1 |
0.0000 |
| 77 |
DYSPHONIA |
2 |
0.0000 |
| 78 |
ASCITES |
1 |
0.0000 |
| 79 |
HEPATIC FAILURE |
1 |
0.0000 |
| 80 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 81 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 82 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 83 |
EYE DISORDER |
1 |
0.0000 |
| 84 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 85 |
URINARY RETENTION |
1 |
0.0000 |
| 86 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 87 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 88 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 89 |
CONDITION AGGRAVATED |
7 |
0.0000 |
| 90 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 91 |
ARRHYTHMIA |
1 |
0.0000 |
| 92 |
COLORECTAL CANCER |
1 |
0.0000 |
| 93 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 94 |
PANCREATITIS |
1 |
0.0000 |
| 95 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 96 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 97 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 98 |
FLATULENCE |
1 |
0.0000 |
| 99 |
EYE IRRITATION |
1 |
0.0000 |
| 100 |
WHEEZING |
1 |
0.0000 |
| 101 |
STOMATITIS |
1 |
0.0000 |
| 102 |
DISCOMFORT |
1 |
0.0000 |
| 103 |
FEELING HOT |
1 |
0.0000 |
| 104 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 105 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 106 |
AMNESIA |
1 |
0.0000 |
| 107 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 108 |
BURNING SENSATION |
1 |
0.0000 |
| 109 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 110 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 111 |
AGITATION |
1 |
0.0000 |
| 112 |
DYSGEUSIA |
1 |
0.0000 |
| 113 |
PRURITUS |
5 |
0.0000 |
| 114 |
DRY MOUTH |
1 |
0.0000 |
| 115 |
DRUG INEFFECTIVE |
16 |
0.0000 |
| 116 |
RASH |
5 |
0.0000 |
| 117 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 118 |
WEIGHT DECREASED |
3 |
0.0000 |
| 119 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 120 |
DYSPHAGIA |
1 |
0.0000 |
| 121 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 122 |
CONTUSION |
1 |
0.0000 |
| 123 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 124 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 125 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 126 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 127 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 128 |
OVERDOSE |
2 |
0.0000 |
| 129 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 130 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 131 |
PSORIASIS |
1 |
0.0000 |
| 132 |
RENAL FAILURE |
1 |
0.0000 |
| 133 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 134 |
VISION BLURRED |
1 |
0.0000 |
| 135 |
DYSPNOEA |
4 |
0.0000 |
| 136 |
INFECTION |
1 |
0.0000 |
| 137 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 138 |
HOSPITALISATION |
1 |
0.0000 |
| 139 |
DRUG INTERACTION |
1 |
0.0000 |
| 140 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 141 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 142 |
PYREXIA |
2 |
0.0000 |
| 143 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 144 |
CHEST PAIN |
1 |
0.0000 |
| 145 |
ANAEMIA |
1 |
0.0000 |
| 146 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 147 |
FATIGUE |
4 |
0.0000 |
| 148 |
HYPOTENSION |
1 |
0.0000 |
| 149 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 150 |
DIARRHOEA |
3 |
0.0000 |
| 151 |
DEPRESSION |
1 |
0.0000 |
| 152 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 153 |
DECREASED APPETITE |
1 |
0.0000 |
| 154 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 155 |
COUGH |
1 |
0.0000 |
| 156 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 157 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 158 |
FALL |
1 |
0.0000 |
| 159 |
DEATH |
2 |
0.0000 |
| 160 |
MALAISE |
1 |
0.0000 |
| 161 |
VOMITING |
1 |
0.0000 |
| 162 |
DIZZINESS |
1 |
0.0000 |
| 163 |
PAIN |
1 |
0.0000 |
| 164 |
NAUSEA |
1 |
0.0000 |
| 165 |
OFF LABEL USE |
1 |
0.0000 |